| ￥3300 | |
| Z05730-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | Baculovirus-Insect Cells | ||||
| Theoretical Molecular Weight | 52.82 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 52.82 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 10% Glycerol, 3mM DTT (pH 8.0). | ||||
| Concentration | Verified by one or more methods from A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -80 °C or below. Avoid repeated freeze-thaw cycles. |
The purity of PAH (D415N), His, Human is greater than 95% as determined by SEC-HPLC. »
PAH (D415N), His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Phenylalanine hydroxylase (PAH) is a member of aromatic amino acid hydroxylase (AAAHs) family, and catalyze phenylalanine (Phe) into tyrosine (Tyr). PAH is also an allosteric enzyme that maintains phenylalanine (Phe) below neurotoxic levels; its failure results in phenylketonuria, an inborn error of amino acid metabolism. |
| Synonyms | PH; PKU; PKU1; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
